Send us a Message



 Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) RatMine GViewer (Genome Viewer) Overgo Probe Designer VCMap
Aging & Age-Related Disease Cancer Cardiovascular Disease COVID-19 Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models   new Genetic Models Autism Models PhenoMiner (Quantitative Phenotypes) Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes GERRC (Gene Editing Rat Resource Center) Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Poster Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
PhenoMiner Database Result        View data table  |  Download data table  |  View compact data table        

Generate Chart For    
    (Chart displayed below)
Rat Strains
{{sample.term}}
Measurement Methods
{{method.term}}
Age
{{ageRange}}
Experimental Conditions
     {{ cond }}

Minimum Value:    Maximum Value:    Sex:


 
Options:  View chart  |  Download data table  |  View compact data table
Study IDStudyExperiment NameExperiment NotesStrain Ont IDStrainSexAge# of AnimalsSample NotesClinical Measurement Ont IDPhenotypeFormulaClinical Measurement NotesAverage TypeValueUnitsSEMSDMethod Ont IDMethodMethod SiteMethod DurationMethod NotesPost Insult TypePost Insult Time ValuePost Insult Time UnitConditionsRecord IDCondition 1Condition 2Condition 3
3038Landau D, et al., J Endocrinol. 2008 Apr;197(1):75-83. doi: 10.1677/JOE-08-0040.blood glucose amountRS:0000677SBH/Yglmale98 days7CMO:0000046blood glucose level383.4mg/dl21.657.1482MMO:0000165electro-chemical glucometer0.0controlled sodium chloride content diet (0.65 %) (for 98 days) then streptozotocin (60 mg/kg) then insulin (10 ul) (for 42 days)106694controlled sodium chloride content diet (0.65 %) (for 98 days)streptozotocin (60 mg/kg) insulin (10 ul) (for 42 days)
3038Landau D, et al., J Endocrinol. 2008 Apr;197(1):75-83. doi: 10.1677/JOE-08-0040.blood glucose amountRS:0000677SBH/Yglmale98 days7CMO:0000046blood glucose level361.8mg/dl32.485.7223MMO:0000165electro-chemical glucometer0.0controlled sodium chloride content diet (8 %) (for 42 days) then streptozotocin (60 mg/kg) then insulin (10 ul) (for 42 days)106695controlled sodium chloride content diet (8 %) (for 42 days)streptozotocin (60 mg/kg) insulin (10 ul) (for 42 days)
3038Landau D, et al., J Endocrinol. 2008 Apr;197(1):75-83. doi: 10.1677/JOE-08-0040.arterial blood pressure traitRS:0000677SBH/Yglmale98 days7CMO:0000004systolic blood pressure128mmHg2.05.2915MMO:0000031tail cuff plethysmography0.0controlled sodium chloride content diet (0.65 %) (for 98 days) then streptozotocin (60 mg/kg) then insulin (10 ul) (for 42 days)106698controlled sodium chloride content diet (0.65 %) (for 98 days)streptozotocin (60 mg/kg) insulin (10 ul) (for 42 days)
3038Landau D, et al., J Endocrinol. 2008 Apr;197(1):75-83. doi: 10.1677/JOE-08-0040.arterial blood pressure traitRS:0000677SBH/Yglmale98 days7CMO:0000004systolic blood pressure181mmHg2.05.2915MMO:0000031tail cuff plethysmography0.0controlled sodium chloride content diet (8 %) (for 42 days) then streptozotocin (60 mg/kg) then insulin (10 ul) (for 42 days)106699controlled sodium chloride content diet (8 %) (for 42 days)streptozotocin (60 mg/kg) insulin (10 ul) (for 42 days)
3038Landau D, et al., J Endocrinol. 2008 Apr;197(1):75-83. doi: 10.1677/JOE-08-0040.heart massRS:0000677SBH/Yglmale98 days7CMO:0000017heart weight1.071g0.0690.1826MMO:0000005post excision weight measurement0.0controlled sodium chloride content diet (0.65 %) (for 98 days) then streptozotocin (60 mg/kg) then insulin (10 ul) (for 42 days)106710controlled sodium chloride content diet (0.65 %) (for 98 days)streptozotocin (60 mg/kg) insulin (10 ul) (for 42 days)
3038Landau D, et al., J Endocrinol. 2008 Apr;197(1):75-83. doi: 10.1677/JOE-08-0040.heart massRS:0000677SBH/Yglmale98 days7CMO:0000017heart weight1.032g0.0770.2037MMO:0000005post excision weight measurement0.0controlled sodium chloride content diet (8 %) (for 42 days) then streptozotocin (60 mg/kg) then insulin (10 ul) (for 42 days)106711controlled sodium chloride content diet (8 %) (for 42 days)streptozotocin (60 mg/kg) insulin (10 ul) (for 42 days)
3038Landau D, et al., J Endocrinol. 2008 Apr;197(1):75-83. doi: 10.1677/JOE-08-0040.heart left ventricle end-diastolic diameterRS:0000677SBH/Yglmale98 days7CMO:0000985heart left ventricle fractional shortening61%4.010.583MMO:0000002transthoracic echocardiography0.0controlled sodium chloride content diet (0.65 %) (for 98 days) then streptozotocin (60 mg/kg) then insulin (10 ul) (for 42 days)106714controlled sodium chloride content diet (0.65 %) (for 98 days)streptozotocin (60 mg/kg) insulin (10 ul) (for 42 days)
3038Landau D, et al., J Endocrinol. 2008 Apr;197(1):75-83. doi: 10.1677/JOE-08-0040.heart left ventricle end-diastolic diameterRS:0000677SBH/Yglmale98 days7CMO:0000985heart left ventricle fractional shortening65%1.02.6458MMO:0000002transthoracic echocardiography0.0controlled sodium chloride content diet (8 %) (for 42 days) then streptozotocin (60 mg/kg) then insulin (10 ul) (for 42 days)106715controlled sodium chloride content diet (8 %) (for 42 days)streptozotocin (60 mg/kg) insulin (10 ul) (for 42 days)
3038Landau D, et al., J Endocrinol. 2008 Apr;197(1):75-83. doi: 10.1677/JOE-08-0040.body massRS:0000677SBH/Yglmale98 days7CMO:0000012body weight223g15.039.6863MMO:0000016body weighing method0.0controlled sodium chloride content diet (0.65 %) (for 98 days) then streptozotocin (60 mg/kg) then insulin (10 ul) (for 42 days)106702controlled sodium chloride content diet (0.65 %) (for 98 days)streptozotocin (60 mg/kg) insulin (10 ul) (for 42 days)
3038Landau D, et al., J Endocrinol. 2008 Apr;197(1):75-83. doi: 10.1677/JOE-08-0040.body massRS:0000677SBH/Yglmale98 days7CMO:0000012body weight216g13.034.3948MMO:0000016body weighing method0.0controlled sodium chloride content diet (8 %) (for 42 days) then streptozotocin (60 mg/kg) then insulin (10 ul) (for 42 days)106703controlled sodium chloride content diet (8 %) (for 42 days)streptozotocin (60 mg/kg) insulin (10 ul) (for 42 days)
3038Landau D, et al., J Endocrinol. 2008 Apr;197(1):75-83. doi: 10.1677/JOE-08-0040.eating behavior traitRS:0000677SBH/Yglmale84 days7CMO:0002214food intake weight to body weight ratio18.04g/d/100g0.822.1695MMO:0000620food intake measuring method0.0controlled sodium chloride content diet (0.65 %) (for 84 days) then streptozotocin (60 mg/kg) then insulin (10 ul) (for 28 days)106706controlled sodium chloride content diet (0.65 %) (for 84 days)streptozotocin (60 mg/kg) insulin (10 ul) (for 28 days)
3038Landau D, et al., J Endocrinol. 2008 Apr;197(1):75-83. doi: 10.1677/JOE-08-0040.eating behavior traitRS:0000677SBH/Yglmale84 days7CMO:0002214food intake weight to body weight ratio15.72g/d/100g0.71.852MMO:0000620food intake measuring method0.0controlled sodium chloride content diet (8 %) (for 28 days) then streptozotocin (60 mg/kg) then insulin (10 ul) (for 28 days)106707controlled sodium chloride content diet (8 %) (for 28 days)streptozotocin (60 mg/kg) insulin (10 ul) (for 28 days)
3038Landau D, et al., J Endocrinol. 2008 Apr;197(1):75-83. doi: 10.1677/JOE-08-0040.heart left ventricle end-systolic diameterRS:0000677SBH/Yglmale98 days7CMO:0002869heart left ventricle end-systolic diameter to body weight ratio0.99mm/kg0.10.2646MMO:0000002transthoracic echocardiography0.0controlled sodium chloride content diet (0.65 %) (for 98 days) then streptozotocin (60 mg/kg) then insulin (10 ul) (for 42 days)106722controlled sodium chloride content diet (0.65 %) (for 98 days)streptozotocin (60 mg/kg) insulin (10 ul) (for 42 days)
3038Landau D, et al., J Endocrinol. 2008 Apr;197(1):75-83. doi: 10.1677/JOE-08-0040.heart left ventricle end-systolic diameterRS:0000677SBH/Yglmale98 days7CMO:0002869heart left ventricle end-systolic diameter to body weight ratio0.95mm/kg0.090.2381MMO:0000002transthoracic echocardiography0.0controlled sodium chloride content diet (8 %) (for 42 days) then streptozotocin (60 mg/kg) then insulin (10 ul) (for 42 days)106723controlled sodium chloride content diet (8 %) (for 42 days)streptozotocin (60 mg/kg) insulin (10 ul) (for 42 days)
3038Landau D, et al., J Endocrinol. 2008 Apr;197(1):75-83. doi: 10.1677/JOE-08-0040.heart left ventricle end-diastolic diameterRS:0000677SBH/Yglmale98 days7CMO:0003220heart left ventricle end-diastolic diameter to body weight ratio2.6mm/kg0.20.5292MMO:0000002transthoracic echocardiography0.0controlled sodium chloride content diet (0.65 %) (for 98 days) then streptozotocin (60 mg/kg) then insulin (10 ul) (for 42 days)106718controlled sodium chloride content diet (0.65 %) (for 98 days)streptozotocin (60 mg/kg) insulin (10 ul) (for 42 days)
3038Landau D, et al., J Endocrinol. 2008 Apr;197(1):75-83. doi: 10.1677/JOE-08-0040.heart left ventricle end-diastolic diameterRS:0000677SBH/Yglmale98 days7CMO:0003220heart left ventricle end-diastolic diameter to body weight ratio2.7mm/kg0.10.2646MMO:0000002transthoracic echocardiography0.0controlled sodium chloride content diet (8 %) (for 42 days) then streptozotocin (60 mg/kg) then insulin (10 ul) (for 42 days)106719controlled sodium chloride content diet (8 %) (for 42 days)streptozotocin (60 mg/kg) insulin (10 ul) (for 42 days)

Contact Us |  About Us |  Jobs at RGD